ClinicalTrials.Veeva

Menu

Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure (PhysioSync-HF)

H

Hospital Moinhos de Vento

Status

Active, not recruiting

Conditions

Conduction System Pacing
Left Bundle-Branch Block
Heart Failure
Cardiac Resynchronization

Treatments

Device: Conduction system pacing
Device: Biventricular pacing

Study type

Interventional

Funder types

Other

Identifiers

NCT05572736
NUP: 25000.123471/2021-59

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of conduction system pacing versus biventricular pacing in patients with chronic heart failure with reduced ejection fraction and left bundle branch block.

Enrollment

179 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female, age ≥18 years
  • Established diagnosis of symptomatic heart failure (New York Heart Association class II-III)
  • Left ventricular ejection fraction ≤35% in prior 3 months
  • Left bundle branch block (QRS ≥130 ms)
  • Clinical indication for cardiac resynchronization therapy
  • Patients should be clinically stable
  • Patients should receive background standard of care for heart failure with reduced ejection fraction, with the maximum tolerated doses of ACE inhibitor or ARB or ARNI, beta-blocker, and mineralocorticoid receptor antagonist

Exclusion criteria

  • Life expectancy <12 months due to any disease
  • Dementia or advanced cerebrovascular disease
  • NYHA class IV
  • Plan to implant an implantable cardioverter defibrillator (ICD), with or without resynchronization therapy (CRT-D)
  • Enrollment in other clinical trials involving cardiac pacing
  • Pregnancy or pre-menopausal women who do not use regular contraceptive methods
  • Patients unable to understand and sign the consent for participation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

179 participants in 2 patient groups

Conduction system pacing
Experimental group
Description:
Patients will be randomized 1:1 to either conduction system pacing or biventricular pacing.
Treatment:
Device: Conduction system pacing
Biventricular pacing
Active Comparator group
Description:
Patients will be randomized 1:1 to either conduction system pacing or biventricular pacing.
Treatment:
Device: Biventricular pacing

Trial contacts and locations

14

Loading...

Central trial contact

Andre Zimerman, MD PhD; Caique Ternes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems